The role of platelets in the recruitment of leukocytes during vascular disease

References

• Jackson SP. Arterial thrombosis – Insidious, unpredictable and deadly. Nat Med 2011;17:1423–1436
   PubMed Web of Science ®Google Scholar
• Hoebe K, Janssen E, Beutler B. The interface between innate and adaptive immunity. Nat Immunol 2004;5:971–974
   PubMed Web of Science ®Google Scholar
• Dunon D, Piali L, Imhof BA. To stick or not to stick: The new leukocyte homing paradigm. Curr Opin Cell Biol 1996;8:714–723
   PubMed Web of Science ®Google Scholar
• Liu Y, Shaw SK, Ma S, Yang L, Luscinskas FW, Parkos CA. Regulation of leukocyte transmigration: Cell surface interactions and signaling events. J Immunol 2004;172:7–13
   PubMed Web of Science ®Google Scholar
• Springer TA. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 1995;57:827–872
   PubMed Web of Science ®Google Scholar
• Kansas GS. Selectins and their ligands: Current concepts and controversies. Blood 1996;88:3259–3287
   PubMed Web of Science ®Google Scholar
• Lawrence MB, Springer TA. Leukocytes roll on a selectin at physiologic flow rates: Distinction from and prerequisite for adhesion through integrins. Cell 1991;65:859–873
   PubMed Web of Science ®Google Scholar
• Takahashi M, Masuyama J, Ikeda U, Kitagawa S, Kasahara T, Saito M, Kano S, Shimada K. Effects of endogenous endothelial interleukin-8 on neutrophil migration across an endothelial monolayer. Cardiovasc Res 1995;29:670–675
   PubMed Web of Science ®Google Scholar
• Luu NT, Rainger GE, Nash GB. Differential ability of exogenous chemotactic agents to disrupt transendothelial migration of flowing neutrophils. J Immunol 2000;164:5961–5969
   PubMed Web of Science ®Google Scholar
• Rainger GE, Fisher AC, Nash GB. Endothelial-borne platelet-activating factor and interleukin-8 rapidly immobilize rolling neutrophils. Am J Physiol 1997;272:H114–H122
   PubMed Web of Science ®Google Scholar
• Belanger C, Elimam H, Lefebvre J, Borgeat P, Marleau S. Involvement of endogenous leukotriene b4 and platelet-activating factor in polymorphonuclear leucocyte recruitment to dermal inflammatory sites in rats. Immunology 2008;124:295–303
   PubMed Web of Science ®Google Scholar
• Kim ND, Chou RC, Seung E, Tager AM, Luster AD. A unique requirement for the leukotriene b4 receptor blt1 for neutrophil recruitment in inflammatory arthritis. J Exp Med 2006;203:829–835
   PubMed Web of Science ®Google Scholar
• Prescott SM, Zimmerman GA, Stafforini DM, McIntyre TM. Platelet-activating factor and related lipid mediators. Annu Rev Biochem 2000;69:419–445
   PubMed Web of Science ®Google Scholar
• Rollin S, Lemieux C, Maliba R, Favier J, Villeneuve LR, Allen BG, Soker S, Bazan NG, Merhi Y, Sirois MG. Vegf-mediated endothelial p-selectin translocation: Role of vegf receptors and endogenous paf synthesis. Blood 2004;103:3789–3797
   PubMed Web of Science ®Google Scholar
• Ahmed SR, McGettrick HM, Yates CM, Buckley CD, Ratcliffe MJ, Nash GB, Rainger GE. Prostaglandin D2 regulates CD4+ memory T cell trafficking across blood vascular endothelium and primes these cells for clearance across lymphatic endothelium. J Immunol 2011;187:1432–1439
   PubMed Web of Science ®Google Scholar
• Muller WA. The role of pecam-1 (cd31) in leukocyte emigration: Studies in vitro and in vivo. J Leukoc Biol 1995;57:523–528
   PubMed Web of Science ®Google Scholar
• Muller WA. Mechanisms of transendothelial migration of leukocytes. Circ Res 2009;105:223–230
   PubMed Web of Science ®Google Scholar
• Serhan CN, Brain SD, Buckley CD, Gilroy DW, Haslett C, O'Neill LA, Perretti M, Rossi AG, Wallace JL. Resolution of inflammation: State of the art, definitions and terms. FASEB J 2007;21:325–332
   PubMed Web of Science ®Google Scholar
• Hamburger SA, McEver RP. Gmp-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990;75:550–554
   PubMed Web of Science ®Google Scholar
• Larsen E, Celi A, Gilbert GE, Furie BC, Erban JK, Bonfanti R, Wagner DD, Furie B. Padgem protein: A receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 1989;59:305–312
   PubMed Web of Science ®Google Scholar
• Buttrum SM, Hatton R, Nash GB. Selectin-mediated rolling of neutrophils on immobilized platelets. Blood 1993;82:1165–1174
   PubMed Web of Science ®Google Scholar
• Lalor P, Nash GB. Adhesion of flowing leucocytes to immobilized platelets. Br J Haematol 1995;89:725–732
   PubMed Web of Science ®Google Scholar
• Stone PC, Nash GB. Conditions under which immobilized platelets activate as well as capture flowing neutrophils. Br J Haematol 1999;105:514–522
   PubMed Web of Science ®Google Scholar
• Weber C, Springer TA. Neutrophil accumulation on activated, surface-adherent platelets in flow is mediated by interaction of mac-1 with fibrinogen bound to alphaiibbeta3 and stimulated by platelet-activating factor. J Clin Invest 1997;100:2085–2093
   PubMed Web of Science ®Google Scholar
• Ostrovsky L, King AJ, Bond S, Mitchell D, Lorant DE, Zimmerman GA, Larsen R, Niu XF, Kubes P. A juxtacrine mechanism for neutrophil adhesion on platelets involves platelet-activating factor and a selectin-dependent activation process. Blood 1998;91:3028–3036
   PubMed Web of Science ®Google Scholar
• Antoine C, Murphy RC, Henson PM, Maclouf J. Time-dependent utilization of platelet arachidonic acid by the neutrophil in formation of 5-lipoxygenase products in platelet-neutrophil co-incubations. Biochim Biophys Acta 1992;1128:139–146
   PubMed Web of Science ®Google Scholar
• Power CA, Furness RB, Brawand C, Wells TN. Cloning of a full-length cDNA encoding the neutrophil-activating peptide ena-78 from human platelets. Gene 1994;151:333–334
   PubMed Web of Science ®Google Scholar
• Su SB, Mukaida N, Matsushima K. Rapid secretion of intracellularly pre-stored interleukin-8 from rabbit platelets upon activation. J Leukoc Biol 1996;59:420–426
   PubMed Web of Science ®Google Scholar
• Diacovo TG, Roth SJ, Buccola JM, Bainton DF, Springer TA. Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of p-selectin and the beta 2-integrin cd11b/cd18. Blood 1996;88:146–157
   PubMed Web of Science ®Google Scholar
• Sheikh S, Nash GB. Continuous activation and deactivation of integrin cd11b/cd18 during de novo expression enables rolling neutrophils to immobilize on platelets. Blood 1996;87:5040–5050
   PubMed Web of Science ®Google Scholar
• Rainger GE, Buckley C, Simmons DL, Nash GB. Cross-talk between cell adhesion molecules regulates the migration velocity of neutrophils. Curr Biol 1997;7:316–325
   PubMed Web of Science ®Google Scholar
• Rainger GE, Buckley CD, Simmons DL, Nash GB. Neutrophils sense flow-generated stress and direct their migration through alphavbeta3-integrin. Am J Physiol 1999;276:H858–H864
   PubMed Web of Science ®Google Scholar
• Rainger GE, Buckley C, Simmons DL, Nash GB. Neutrophils rolling on immobilised platelets migrate into homotypic aggregates after activation. Thromb Haemost 1998;79:1177–1183
   PubMed Web of Science ®Google Scholar
• Ware JA, Heistad DD. Seminars in medicine of the beth israel hospital, boston. Platelet-endothelium interactions. N Engl J Med 1993;328:628–635
   PubMed Web of Science ®Google Scholar
• Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987;2:1057–1058
   PubMed Web of Science ®Google Scholar
• Radomski MW, Palmer RM, Moncada S. The anti-aggregating properties of vascular endothelium: Interactions between prostacyclin and nitric oxide. Br J Pharmacol 1987;92:639–646
   PubMed Web of Science ®Google Scholar
• Radomski MW, Palmer RM, Moncada S. Modulation of platelet aggregation by an l-arginine-nitric oxide pathway. Trends Pharmacol Sci 1991;12:87–88
   PubMed Web of Science ®Google Scholar
• Davies MJ, Woolf N, Rowles PM, Pepper J. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J 1988;60:459–464
   PubMedGoogle Scholar
• Rosenblum WI. Platelet adhesion and aggregation without endothelial denudation or exposure of basal lamina and/or collagen. J Vasc Res 1997;34:409–417
   PubMed Web of Science ®Google Scholar
• Kuijper PH, Gallardo Tores HI, Lammers JW, Sixma JJ, Koenderman L, Zwaginga JJ. Platelet associated fibrinogen and icam-2 induce firm adhesion of neutrophils under flow conditions. Thromb Haemost 1998;80:443–448
   PubMed Web of Science ®Google Scholar
• Bombeli T, Schwartz BR, Harlan JM. Adhesion of activated platelets to endothelial cells: Evidence for a gpiibiiia-dependent bridging mechanism and novel roles for endothelial intercellular adhesion molecule 1 (icam-1), alphavbeta3 integrin, and gpibalpha. J Exp Med 1998;187:329–339
   PubMed Web of Science ®Google Scholar
• Gawaz M, Neumann FJ, Dickfeld T, Reininger A, Adelsberger H, Gebhardt A, Schomig A. Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: Implications for reperfusion in acute myocardial infarction. Circulation 1997;96:1809–1818
   PubMed Web of Science ®Google Scholar
• Kaplan JE, Moon DG, Weston LK, Minnear FL, Del Vecchio PJ, Shepard JM, Fenton JW II. Platelets adhere to thrombin-treated endothelial cells in vitro. Am J Physiol 1989;257:H423–H433
   PubMed Web of Science ®Google Scholar
• Kirton CM, Nash GB. Activated platelets adherent to an intact endothelial cell monolayer bind flowing neutrophils and enable them to transfer to the endothelial surface. J Lab Clin Med 2000;136:303–313
   PubMed Web of Science ®Google Scholar
• Kuckleburg CJ, Yates CM, Kalia N, Zhao Y, Nash GB, Watson SP, Rainger GE. Endothelial cell-borne platelet bridges selectively recruit monocytes in human and mouse models of vascular inflammation. Cardiovasc Res 2011;91:134–141
   PubMed Web of Science ®Google Scholar
• Lagadec P, Dejoux O, Ticchioni M, Cottrez F, Johansen M, Brown EJ, Bernard A. Involvement of a cd47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow. Blood 2003;101:4836–4843
   PubMed Web of Science ®Google Scholar
• Radomski MW, Vallance P, Whitley G, Foxwell N, Moncada S. Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res 1993;27:1380–1382
   PubMed Web of Science ®Google Scholar
• Reininger AJ, Agneskirchner J, Bode PA, Spannagl M, Wurzinger LJ. C7e3 fab inhibits low shear flow modulated platelet adhesion to endothelium and surface-absorbed fibrinogen by blocking platelet gp iib/iiia as well as endothelial vitronectin receptor – Results from patients with acute myocardial infarction and healthy controls. Thromb Haemost 2000;83:217–223
   PubMed Web of Science ®Google Scholar
• Reininger AJ, Korndorfer MA, Wurzinger LJ. Adhesion of adp-activated platelets to intact endothelium under stagnation point flow in vitro is mediated by the integrin alphaiibeta3. Thromb Haemost 1998;79:998–1003
   PubMed Web of Science ®Google Scholar
• Rosenblum WI, Nelson GH, Wormley B, Werner P, Wang J, Shih CC. Role of platelet-endothelial cell adhesion molecule (pecam) in platelet adhesion/aggregation over injured but not denuded endothelium in vivo and ex vivo. Stroke 1996;27:709–711
   PubMed Web of Science ®Google Scholar
• Shanberge JN, Kajiwara Y, Quattrociocchi-Longe T. Effect of aspirin and iloprost on adhesion of platelets to intact endothelium in vivo. J Lab Clin Med 1995;125:96–101
   PubMed Web of Science ®Google Scholar
• Tomita Y, Tanahashi N, Tomita M, Itoh Y, Yokoyama M, Takeda H, Schiszler I, Fukuuchi Y. Role of platelet glycoprotein iib/iiia in adp-activated platelet adhesion to aortic endothelial cells in vitro: Observation with video-enhanced contrast microscopy. Clin Hemorheol Microcirc 2001;24:1–9
   PubMed Web of Science ®Google Scholar
• Tull SP, Anderson SI, Hughan SC, Watson SP, Nash GB, Rainger GE. Cellular pathology of atherosclerosis: Smooth muscle cells promote adhesion of platelets to cocultured endothelial cells. Circ Res 2006;98:98–104
   PubMed Web of Science ®Google Scholar
• Venturini CM, Weston LK, Kaplan JE. Platelet cgmp, but not camp, inhibits thrombin-induced platelet adhesion to pulmonary vascular endothelium. Am J Physiol 1992;263:H606–H612
   PubMed Web of Science ®Google Scholar
• Andre P, Denis CV, Ware J, Saffaripour S, Hynes RO, Ruggeri ZM, Wagner DD. Platelets adhere to and translocate on von willebrand factor presented by endothelium in stimulated veins. Blood 2000;96:3322–3328
   PubMed Web of Science ®Google Scholar
• Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein e. Nat Med 2003;9:61–67
   PubMed Web of Science ®Google Scholar
• Massberg S, Brand K, Gruner S, Page S, Muller E, Muller I, Bergmeier W, Richter T, Lorenz M, Konrad I, Nieswandt B, Gawaz M. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med 2002;196:887–896
   PubMed Web of Science ®Google Scholar
• Frenette PS, Johnson RC, Hynes RO, Wagner DD. Platelets roll on stimulated endothelium in vivo: An interaction mediated by endothelial p-selectin. Proc Natl Acad Sci USA 1995;92:7450–7454
   PubMed Web of Science ®Google Scholar
• van Gils JM, da Costa Martins PA, Mol A, Hordijk PL, Zwaginga JJ. Transendothelial migration drives dissociation of plateletmonocyte complexes. Thromb Haemost 2008;100:271–279
   PubMed Web of Science ®Google Scholar
• Kuijper PH, Gallardo Torres HI, van der Linden JA, Lammers JW, Sixma JJ, Koenderman L, Zwaginga JJ. Platelet-dependent primary hemostasis promotes selectin- and integrin-mediated neutrophil adhesion to damaged endothelium under flow conditions. Blood 1996;87:3271–3281
   PubMed Web of Science ®Google Scholar
• Bahra P, Nash GB. Sparsely adherent platelets support capture and immobilization of flowing neutrophils. J Lab Clin Med 1998;132:223–228
   PubMedGoogle Scholar
• Butler LM, Metson-Scott T, Felix J, Abhyankar A, Rainger GE, Farndale RW, Watson SP, Nash GB. Sequential adhesion of platelets and leukocytes from flowing whole blood onto a collagen-coated surface: Requirement for a gpvi-binding site in collagen. Thromb Haemost 2007;97:814–821
   PubMed Web of Science ®Google Scholar
• Skilbeck CA, Walker PG, David T, Nash GB. Disturbed flow promotes deposition of leucocytes from flowing whole blood in a model of a damaged vessel wall. Br J Haematol 2004;126:418–427
   PubMed Web of Science ®Google Scholar
• da Costa Martins P, van den Berk N, Ulfman LH, Koenderman L, Hordijk PL, Zwaginga JJ. Platelet-monocyte complexes support monocyte adhesion to endothelium by enhancing secondary tethering and cluster formation. Arterioscler Thromb Vasc Biol 2004;24:193–199
   PubMed Web of Science ®Google Scholar
• Li N. Platelet-lymphocyte cross-talk. J Leukoc Biol 2008;83:1069–1078
   PubMed Web of Science ®Google Scholar
• Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interactions: Linking hemostasis and inflammation. Blood Rev 2007;21:99–111
   PubMed Web of Science ®Google Scholar
• von Hundelshausen P, Weber KS, Huo Y, Proudfoot AE, Nelson PJ, Ley K, Weber C. Rantes deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 2001;103:1772–1777
   PubMed Web of Science ®Google Scholar
• Schulz C, Schafer A, Stolla M, Kerstan S, Lorenz M, von Bruhl ML, Schiemann M, Bauersachs J, Gloe T, Busch DH, et al. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: A critical role for p-selectin expressed on activated platelets. Circulation 2007;116:764–773
   PubMed Web of Science ®Google Scholar
• van Gils JM, Zwaginga JJ, Hordijk PL. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol 2009;85:195–204
   PubMed Web of Science ®Google Scholar
• Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Dynamics of leukocyte-platelet adhesion in whole blood. Blood 1991;78:1730–1737
   PubMed Web of Science ®Google Scholar
• Japp AG, Chelliah R, Tattersall L, Lang NN, Meng X, Weisel K, Katz A, Burt D, Fox KA, Feuerstein GZ, et al. Effect of psi-697, a novel p-selectin inhibitor, on platelet-monocyte aggregate formation in humans. J Am Heart Assoc 2013;2:e006007
   PubMed Web of Science ®Google Scholar
• Kling D, Stucki C, Kronenberg S, Tuerck D, Rheaume E, Tardif JC, Gaudreault J, Schmitt C. Pharmacological control of platelet-leukocyte interactions by the human anti-p-selectin antibody inclacumab – Preclinical and clinical studies. Thromb Res 2013;131:401–410
   PubMed Web of Science ®Google Scholar
• Fernandes LS, Conde ID, Wayne Smith C, Kansas GS, Snapp KR, Bennet N, Ballantyne C, McIntire LV, O'Brian Smith E, Klem JA, et al. Platelet-monocyte complex formation: Effect of blocking psgl-1 alone, and in combination with alphaiibbeta3 and alphambeta2, in coronary stenting. Thromb Res 2003;111:171–177
   PubMed Web of Science ®Google Scholar
• Simon DI, Chen Z, Xu H, Li CQ, Dong J, McIntire LV, Ballantyne CM, Zhang L, Furman MI, Berndt MC, et al. Platelet glycoprotein ibalpha is a counterreceptor for the leukocyte integrin mac-1 (cd11b/cd18). J Exp Med 2000;192:193–204
   PubMed Web of Science ®Google Scholar
• Yip C, Ignjatovic V, Attard C, Monagle P, Linden MD. First report of elevated monocyte-platelet aggregates in healthy children. PLoS One 2013;8:e67416
   PubMedGoogle Scholar
• Elalamy I, Chakroun T, Gerotziafas GT, Petropoulou A, Robert F, Karroum A, Elgrably F, Samama MM, Hatmi M. Circulating platelet-leukocyte aggregates: A marker of microvascular injury in diabetic patients. Thromb Res 2008;121:843–848
   PubMed Web of Science ®Google Scholar
• Harding SA, Sommerfield AJ, Sarma J, Twomey PJ, Newby DE, Frier BM, Fox KA. Increased cd40 ligand and platelet-monocyte aggregates in patients with type 1 diabetes mellitus. Atherosclerosis 2004;176:321–325
   PubMed Web of Science ®Google Scholar
• Joseph JE, Harrison P, Mackie IJ, Isenberg DA, Machin SJ. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br J Haematol 2001;115:451–459
   PubMed Web of Science ®Google Scholar
• Tekelioglu Y, Uzun H, Gucer H. Circulating platelet-leukocyte aggregates in patients with inflammatory bowel disease. J Chin Med Assoc 2013;76:182–185
   PubMed Web of Science ®Google Scholar
• Wrigley BJ, Shantsila E, Tapp LD, Lip GY. Increased formation of monocyte-platelet aggregates in ischemic heart failure. Circ Heart Fail 2013;6:127–135
   PubMed Web of Science ®Google Scholar
• Goncalves R, Zhang X, Cohen H, Debrabant A, Mosser DM. Platelet activation attracts a subpopulation of effector monocytes to sites of leishmania major infection. J Exp Med 2011;208:1253–1265
   PubMed Web of Science ®Google Scholar
• Parimon T, Li Z, Bolz DD, McIndoo ER, Bayer CR, Stevens DL, Bryant AE. Staphylococcus aureus alpha-hemolysin promotes platelet-neutrophil aggregate formation. J Infect Dis 2013;208:761–770
   PubMed Web of Science ®Google Scholar
• Furman MI, Barnard MR, Krueger LA, Fox ML, Shilale EA, Lessard DM, Marchese P, Frelinger AL III, Goldberg RJ, Michelson AD. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001;38:1002–1006
   PubMed Web of Science ®Google Scholar
• Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC, Hechtman HB, Michelson AD. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998;31:352–358
   PubMed Web of Science ®Google Scholar
• Htun P, Fateh-Moghadam S, Tomandl B, Handschu R, Klinger K, Stellos K, Garlichs C, Daniel W, Gawaz M. Course of platelet activation and platelet-leukocyte interaction in cerebrovascular ischemia. Stroke 2006;37:2283–2287
   PubMed Web of Science ®Google Scholar
• McCabe DJ, Harrison P, Mackie IJ, Sidhu PS, Purdy G, Lawrie AS, Watt H, Brown MM, Machin SJ. Platelet degranulation and monocyte-platelet complex formation are increased in the acute and convalescent phases after ischaemic stroke or transient ischaemic attack. Br J Haematol 2004;125:777–787
   PubMed Web of Science ®Google Scholar
• Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface p-selectin: Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001;104:1533–1537
   PubMed Web of Science ®Google Scholar
• Mickelson JK, Lakkis NM, Villarreal-Levy G, Hughes BJ, Smith CW. Leukocyte activation with platelet adhesion after coronary angioplasty: A mechanism for recurrent disease? J Am Coll Cardiol 1996;28:345–353
   PubMed Web of Science ®Google Scholar
• Smout J, Dyker A, Cleanthis M, Ford G, Kesteven P, Stansby G. Platelet function following acute cerebral ischemia. Angiology 2009;60:362–369
   PubMed Web of Science ®Google Scholar
• Gkaliagkousi E, Corrigall V, Becker S, de Winter P, Shah A, Zamboulis C, Ritter J, Ferro A. Decreased platelet nitric oxide contributes to increased circulating monocyte-platelet aggregates in hypertension. Eur Heart J 2009;30:3048–3054
   PubMed Web of Science ®Google Scholar
• Nomura S, Kanazawa S, Fukuhara S. Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus. J Hum Hypertens 2002;16:539–547
   PubMed Web of Science ®Google Scholar
• Lippi G, Montagnana M, Salvagno GL, Cicorella N, Degan M, Minuz P, Lechi C, Guidi GC. Risk stratification of patients with acute myocardial infarction by quantification of circulating monocyte-platelet aggregates. Int J Cardiol 2007;115:101–102
   PubMed Web of Science ®Google Scholar
• Raposo G, Stoorvogel W. Extracellular vesicles: Exosomes, microvesicles, and friends. J Cell Biol 2013;200:373–383
   PubMed Web of Science ®Google Scholar
• Varon D, Hayon Y, Dashevsky O, Shai E. Involvement of platelet derived microparticles in tumor metastasis and tissue regeneration. Thromb Res 2012;130:S98–S99
   PubMed Web of Science ®Google Scholar
• Barteneva NS, Fasler-Kan E, Bernimoulin M, Stern JN, Ponomarev ED, Duckett L, Vorobjev IA. Circulating microparticles: Square the circle. BMC Cell Biol 2013;14:23
   PubMed Web of Science ®Google Scholar
• Del Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 2005;106:1604–1611
   PubMed Web of Science ®Google Scholar
• Yang C, Xiong W, Qiu Q, Shao Z, Hamel D, Tahiri H, Leclair G, Lachapelle P, Chemtob S, Hardy P. Role of receptor-mediated endocytosis in the antiangiogenic effects of human t lymphoblastic cell-derived microparticles. Am J Physiol Regul Integr Comp Physiol 2012;302:R941–R949
   PubMed Web of Science ®Google Scholar
• Orozco AF, Jorgez CJ, Horne C, Marquez-Do DA, Chapman MR, Rodgers JR, Bischoff FZ, Lewis DE. Membrane protected apoptotic trophoblast microparticles contain nucleic acids: Relevance to preeclampsia. Am J Pathol 2008;173:1595–1608
   PubMed Web of Science ®Google Scholar
• Risitano A, Beaulieu LM, Vitseva O, Freedman JE. Platelets and platelet-like particles mediate intercellular RNA transfer. Blood 2012;119:6288–6295
   PubMed Web of Science ®Google Scholar
• Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee ML, Schmittgen TD, et al. Detection of microrna expression in human peripheral blood microvesicles. PLoS One 2008;3:e3694
   PubMed Web of Science ®Google Scholar
• Barry OP, Pratico D, Lawson JA, FitzGerald GA. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest 1997;99:2118–2127
   PubMed Web of Science ®Google Scholar
• Garcia BA, Smalley DM, Cho H, Shabanowitz J, Ley K, Hunt DF. The platelet microparticle proteome. J Proteome Res 2005;4:1516–1521
   PubMed Web of Science ®Google Scholar
• Flaumenhaft R, Dilks JR, Richardson J, Alden E, Patel-Hett SR, Battinelli E, Klement GL, Sola-Visner M, Italiano JE Jr. Megakaryocyte-derived microparticles: Direct visualization and distinction from platelet-derived microparticles. Blood 2009;113:1112–1121
   PubMed Web of Science ®Google Scholar
• Cloutier N, Tan S, Boudreau LH, Cramb C, Subbaiah R, Lahey L, Albert A, Shnayder R, Gobezie R, Nigrovic PA, et al. The exposure of autoantigens by microparticles underlies the formation of potent inflammatory components: The microparticle-associated immune complexes. EMBO Mol Med 2013;5:235–249
   PubMed Web of Science ®Google Scholar
• Holme PA, Rosger M, Solum NO, Brosstad F, Larsen AM, Hovig T. Glycoprotein iib-iiia on platelet-derived microparticles, and microparticle structures studied by electron microscopy, confocal laser microscopy and crossed radio-immunoelectrophoresis. Platelets 1996;7:207–214
   PubMed Web of Science ®Google Scholar
• Nomura S, Tandon NN, Nakamura T, Cone J, Fukuhara S, Kambayashi J. High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in thp-1 and endothelial cells. Atherosclerosis 2001;158:277–287
   PubMed Web of Science ®Google Scholar
• Shai E, Rosa I, Parguina AF, Motahedeh S, Varon D, Garcia A. Comparative analysis of platelet-derived microparticles reveals differences in their amount and proteome depending on the platelet stimulus. J Proteomics 2012;76:287–296
   PubMed Web of Science ®Google Scholar
• Ogata N, Imaizumi M, Nomura S, Shozu A, Arichi M, Matsuoka M, Matsumura M. Increased levels of platelet-derived microparticles in patients with diabetic retinopathy. Diabetes Res Clin Pract 2005;68:193–201
   PubMed Web of Science ®Google Scholar
• Nomura S, Suzuki M, Katsura K, Xie GL, Miyazaki Y, Miyake T, Kido H, Kagawa H, Fukuhara S. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 1995;116:235–240
   PubMed Web of Science ®Google Scholar
• Feng B, Chen Y, Luo Y, Chen M, Li X, Ni Y. Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. Atherosclerosis 2010;208:264–269
   PubMed Web of Science ®Google Scholar
• Biasucci LM, Porto I, Di Vito L, De Maria GL, Leone AM, Tinelli G, Tritarelli A, Di Rocco G, Snider F, Capogrossi MC, et al. Differences in microparticle release in patients with acute coronary syndrome and stable angina. Circ J 2012;76:2174–2182
   PubMed Web of Science ®Google Scholar
• Tersteeg C, Heijnen HF, Eckly A, Pasterkamp G, Urbanus RT, Maas C, Hoefer IE, Nieuwland R, Farndale RW, Gachet C, et al. Flow-induced protrusions (FLIPRs): A platelet-derived platform for the retrieval of microparticles by monocytes and neutrophils. Circ Res 2014;114:780–791
   PubMed Web of Science ®Google Scholar
• Mause SF, von Hundelshausen P, Zernecke A, Koenen RR, Weber C. Platelet microparticles: A transcellular delivery system for rantes promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 2005;25:1512–1518
   PubMed Web of Science ®Google Scholar
• Barry OP, FitzGerald GA. Mechanisms of cellular activation by platelet microparticles. Thromb Haemost 1999;82:794–800
   PubMed Web of Science ®Google Scholar
• Barry OP, Pratico D, Savani RC, FitzGerald GA. Modulation of monocyte-endothelial cell interactions by platelet microparticles. J Clin Invest 1998;102:136–144
   PubMed Web of Science ®Google Scholar
• Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmerman GA, Weyrich AS. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 2001;154:485–490
   PubMed Web of Science ®Google Scholar
• Forlow SB, McEver RP, Nollert MU. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood 2000;95:1317–1323
   PubMed Web of Science ®Google Scholar
• Diepenhorst GM, van Gulik TM, Hack CE. Complement-mediated ischemia-reperfusion injury: Lessons learned from animal and clinical studies. Ann Surg 2009;249:889–899
   PubMed Web of Science ®Google Scholar
• Harris AG, Leiderer R, Peer F, Messmer K. Skeletal muscle microvascular and tissue injury after varying durations of ischemia. Am J Physiol 1996;271:H2388–H2398
   PubMed Web of Science ®Google Scholar
• Lehr HA, Menger MD, Messmer K. Impact of leukocyte adhesion on myocardial ischemia/reperfusion injury: Conceivable mechanisms and proven facts. J Lab Clin Med 1993;121:539–545
   PubMedGoogle Scholar
• Ley K. Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc Res 1996;32:733–742
   PubMed Web of Science ®Google Scholar
• Nolte D, Hecht R, Schmid P, Botzlar A, Menger MD, Neumueller C, Sinowatz F, Vestweber D, Messmer K. Role of mac-1 and icam-1 in ischemia-reperfusion injury in a microcirculation model of balb/c mice. Am J Physiol 1994;267:H1320–H1328
   PubMed Web of Science ®Google Scholar
• Cywes R, Mullen JB, Stratis MA, Greig PD, Levy GA, Harvey PR, Strasberg SM. Prediction of the outcome of transplantation in man by platelet adherence in donor liver allografts. Evidence of the importance of prepreservation injury. Transplantation 1993;56:316–323
   PubMed Web of Science ®Google Scholar
• Cywes R, Packham MA, Tietze L, Sanabria JR, Harvey PR, Phillips MJ, Strasberg SM. Role of platelets in hepatic allograft preservation injury in the rat. Hepatology 1993;18:635–647
   PubMed Web of Science ®Google Scholar
• Flores NA, Goulielmos NV, Seghatchian MJ, Sheridan DJ. Myocardial ischaemia induces platelet activation with adverse electrophysiological and arrhythmogenic effects. Cardiovasc Res 1994;28:1662–1671
   PubMed Web of Science ®Google Scholar
• Okada Y, Marchevsky AM, Zuo XJ, Pass JA, Kass RM, Matloff JM, Jordan SC. Accumulation of platelets in rat syngeneic lung transplants: A potential factor responsible for preservation-reperfusion injury. Transplantation 1997;64:801–806
   PubMed Web of Science ®Google Scholar
• Khandoga A, Biberthaler P, Messmer K, Krombach F. Platelet-endothelial cell interactions during hepatic ischemia-reperfusion in vivo: A systematic analysis. Microvasc Res 2003;65:71–77
   PubMed Web of Science ®Google Scholar
• Kuroda T, Shiohara E, Homma T, Furukawa Y, Chiba S. Effects of leukocyte and platelet depletion on ischemia – Reperfusion injury to dog pancreas. Gastroenterology 1994;107:1125–1134
   PubMed Web of Science ®Google Scholar
• Chintala MS, Bernardino V, Chiu PJ. Cyclic gmp but not cyclic amp prevents renal platelet accumulation after ischemia-reperfusion in anesthetized rats. J Pharmacol Exp Ther 1994;271:1203–1208
   PubMed Web of Science ®Google Scholar
• Massberg S, Enders G, Leiderer R, Eisenmenger S, Vestweber D, Krombach F, Messmer K. Platelet-endothelial cell interactions during ischemia/reperfusion: The role of p-selectin. Blood 1998;92:507–515
   PubMed Web of Science ®Google Scholar
• Khandoga A, Biberthaler P, Enders G, Axmann S, Hutter J, Messmer K, Krombach F. Platelet adhesion mediated by fibrinogen-intercelllular adhesion molecule-1 binding induces tissue injury in the postischemic liver in vivo. Transplantation 2002;74:681–688
   PubMed Web of Science ®Google Scholar
• Khandoga A, Biberthaler P, Enders G, Teupser D, Axmann S, Luchting B, Hutter J, Messmer K, Krombach F. P-selectin mediates platelet-endothelial cell interactions and reperfusion injury in the mouse liver in vivo. Shock 2002;18:529–535
   PubMed Web of Science ®Google Scholar
• Cooper D, Chitman KD, Williams MC, Granger DN. Time-dependent platelet-vessel wall interactions induced by intestinal ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 2003;284:G1027–G1033
   PubMed Web of Science ®Google Scholar
• Nishijima K, Kiryu J, Tsujikawa A, Honjo M, Nonaka A, Yamashiro K, Tanihara H, Tojo SJ, Ogura Y, Honda Y. In vivo evaluation of platelet – Endothelial interactions after transient retinal ischemia. Invest Ophthalmol Vis Sci 2001;42:2102–2109
   PubMed Web of Science ®Google Scholar
• Russell J, Cooper D, Tailor A, Stokes KY, Granger DN. Low venular shear rates promote leukocyte-dependent recruitment of adherent platelets. Am J Physiol Gastrointest Liver Physiol 2003;284:G123–G129
   PubMed Web of Science ®Google Scholar
• Yadav SS, Howell DN, Steeber DA, Harland RC, Tedder TF, Clavien PA. P-selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver. Hepatology 1999;29:1494–1502
   PubMed Web of Science ®Google Scholar
• Campbell B, Chuhran CM, Lefer DJ, Lefer AM. Cardioprotective effects of abciximab (reopro) in an isolated perfused rat heart model of ischemia and reperfusion. Methods Find Exp Clin Pharmacol 1999;21:529–534
   PubMed Web of Science ®Google Scholar
• Kupatt C, Wichels R, Horstkotte J, Krombach F, Habazettl H, Boekstegers P. Molecular mechanisms of platelet-mediated leukocyte recruitment during myocardial reperfusion. J Leukoc Biol 2002;72:455–461
   PubMed Web of Science ®Google Scholar
• Massberg S, Enders G, Matos FC, Tomic LI, Leiderer R, Eisenmenger S, Messmer K, Krombach F. Fibrinogen deposition at the postischemic vessel wall promotes platelet adhesion during ischemia-reperfusion in vivo. Blood 1999;94:3829–3838
   PubMed Web of Science ®Google Scholar
• Ovechkin AV, Lominadze D, Sedoris KC, Gozal E, Robinson TW, Roberts AM. Inhibition of inducible nitric oxide synthase attenuates platelet adhesion in subpleural arterioles caused by lung ischemia-reperfusion in rabbits. J Appl Physiol (1985) 2005;99:2423–2432
   PubMed Web of Science ®Google Scholar
• Ishikawa M, Sekizuka E, Yamaguchi N, Nakadate H, Terao S, Granger DN, Minamitani H. Angiotensin ii type 1 receptor signaling contributes to platelet-leukocyte-endothelial cell interactions in the cerebral microvasculature. Am J Physiol Heart Circ Physiol 2007;292:H2306–H2315
   PubMed Web of Science ®Google Scholar
• Uhlmann D, Glasser S, Gaebel G, Armann B, Ludwig S, Tannapfel A, Hauss J, Witzigmann H. Improvement of postischemic hepatic microcirculation after endothelina receptor blockade – Endothelin antagonism influences platelet-endothelium interactions. J Gastrointest Surg 2005;9:187–197
   PubMed Web of Science ®Google Scholar
• Osman M, Russell J, Granger DN. Lymphocyte-derived interferon-gamma mediates ischemia-reperfusion-induced leukocyte and platelet adhesion in intestinal microcirculation. Am J Physiol Gastrointest Liver Physiol 2009;296:G659–G663
   PubMed Web of Science ®Google Scholar
• Lefer AM, Campbell B, Scalia R, Lefer DJ. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: Role of selectins. Circulation 1998;98:1322–1328
   PubMed Web of Science ®Google Scholar
• Salter JW, Krieglstein CF, Issekutz AC, Granger DN. Platelets modulate ischemia/reperfusion-induced leukocyte recruitment in the mesenteric circulation. Am J Physiol Gastrointest Liver Physiol 2001;281:G1432–G1439
   PubMed Web of Science ®Google Scholar
• Cooper D, Russell J, Chitman KD, Williams MC, Wolf RE, Granger DN. Leukocyte dependence of platelet adhesion in postcapillary venules. Am J Physiol Heart Circ Physiol 2004;286:H1895–H1900
   PubMed Web of Science ®Google Scholar
• Kuroda T, Shiohara E. Leukocyte and platelet depletion protects the liver from damage induced by cholestasis and ischemia-reperfusion in the dog. Scand J Gastroenterol 1996;31:182–190
   PubMed Web of Science ®Google Scholar
• Singbartl K, Forlow SB, Ley K. Platelet, but not endothelial, p-selectin is critical for neutrophil-mediated acute postischemic renal failure. FASEB J 2001;15:2337–2344
   PubMed Web of Science ®Google Scholar
• Brancaleone V, Gobbetti T, Cenac N, le Faouder P, Colom B, Flower RJ, Vergnolle N, Nourshargh S, Perretti M. A vasculo-protective circuit centered on lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 operative in murine microcirculation. Blood 2013;122:608–617
   PubMed Web of Science ®Google Scholar
• Abdulnour RE, Dalli J, Colby JK, Krishnamoorthy N, Timmons JY, Hwa Tan S, Colas RA, Petasis NA, Serhan CN, Levy BD. Maresin 1 biosynthesis during platelet–neutrophil interactions is organ-protective. Proc Natl Acad Sci USA 2014;111:16526–16531
   PubMed Web of Science ®Google Scholar
• Yago T, Tsukuda M, Minami M. P-selectin binding promotes the adhesion of monocytes to vcam-1 under flow conditions. J Immunol 1999;163:367–373
   PubMed Web of Science ®Google Scholar
• Bouchon A, Dietrich J, Colonna M. Cutting edge: Inflammatory responses can be triggered by trem-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000;164:4991–4995
   PubMed Web of Science ®Google Scholar
• da Costa Martins PA, van Gils JM, Mol A, Hordijk PL, Zwaginga JJ. Platelet binding to monocytes increases the adhesive properties of monocytes by up-regulating the expression and functionality of beta1 and beta2 integrins. J Leukoc Biol 2006;79:499–507
   PubMed Web of Science ®Google Scholar
• Neumann FJ, Marx N, Gawaz M, Brand K, Ott I, Rokitta C, Sticherling C, Meinl C, May A, Schomig A. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets. Circulation 1997;95:2387–2394
   PubMed Web of Science ®Google Scholar
• Passacquale G, Vamadevan P, Pereira L, Hamid C, Corrigall V, Ferro A. Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes. PLoS One 2011;6:e25595
   PubMed Web of Science ®Google Scholar
• Rainger GE, Rowley AF, Nash GB. Adhesion-dependent release of elastase from human neutrophils in a novel, flow-based model: Specificity of different chemotactic agents. Blood 1998;92:4819–4827
   PubMed Web of Science ®Google Scholar
• Scheuerer B, Ernst M, Durrbaum-Landmann I, Fleischer J, Grage-Griebenow E, Brandt E, Flad HD, Petersen F. The cxc-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood 2000;95:1158–1166
   PubMed Web of Science ®Google Scholar
• Nassar T, Sachais BS, Akkawi S, Kowalska MA, Bdeir K, Leitersdorf E, Hiss E, Ziporen L, Aviram M, Cines D, et al. Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells. J Biol Chem 2003;278:6187–6193
   PubMed Web of Science ®Google Scholar
• Gleissner CA, Shaked I, Little KM, Ley K. Cxc chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages. J Immunol 2010;184:4810–4818
   PubMed Web of Science ®Google Scholar
• Gleissner CA, Shaked I, Erbel C, Bockler D, Katus HA, Ley K. Cxcl4 downregulates the atheroprotective hemoglobin receptor cd163 in human macrophages. Circ Res 2010;106:203–211
   PubMed Web of Science ®Google Scholar
• Suzuki J, Hamada E, Shodai T, Kamoshida G, Kudo S, Itoh S, Koike J, Nagata K, Irimura T, Tsuji T. Cytokine secretion from human monocytes potentiated by p-selectin-mediated cell adhesion. Int Arch Allergy Immunol 2013;160:152–160
   PubMed Web of Science ®Google Scholar
• Seta N, Okazaki Y, Miyazaki H, Kato T, Kuwana M. Platelet-derived stromal cell-derived factor-1 is required for the transformation of circulating monocytes into multipotential cells. PLoS One 2013;8:e74246
   PubMedGoogle Scholar
• Seta N, Kuwana M. Derivation of multipotent progenitors from human circulating CD14+ monocytes. Exp Hematol 2010;38:557–563
   PubMed Web of Science ®Google Scholar
• Spectre G, Zhu L, Ersoy M, Hjemdahl P, Savion N, Varon D, Li N. Platelets selectively enhance lymphocyte adhesion on subendothelial matrix under arterial flow conditions. Thromb Haemost 2012;108:328–337
   PubMed Web of Science ®Google Scholar
• von Hundelshausen P, Weber C. Platelets as immune cells: Bridging inflammation and cardiovascular disease. Circ Res 2007;100:27–40
   PubMed Web of Science ®Google Scholar
• Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, et al. Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373:1849–1860
   PubMed Web of Science ®Google Scholar
• Eikelboom JW, Hirsh J, Spencer FA, Baglin TP, Weitz JI. Antiplatelet drugs: Antithrombotic therapy and prevention of thrombosis. American college of chest physicians evidence-based clinical practice guidelines (9th ed). Chest 2012;141:e89S–e119S
   PubMed Web of Science ®Google Scholar
• Patrono C, Andreotti F, Arnesen H, Badimon L, Baigent C, Collet JP, De Caterina R, Gulba D, Huber K, Husted S, et al. Antiplatelet agents for the treatment and prevention of atherothrombosis. Eur Heart J 2011;32:2922–2932
   PubMed Web of Science ®Google Scholar
• Awtry EH, Loscalzo J. Aspirin. Circulation 2000;101:1206–1218
   PubMed Web of Science ®Google Scholar
• Li N, Hu H, Hjemdahl P. Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry. Thromb Res 2003;111:165–170
   PubMed Web of Science ®Google Scholar
• Wallentin L. P2y(12) inhibitors: Differences in properties and mechanisms of action and potential consequences for clinical use. Eur Heart J 2009;30:1964–1977
   PubMed Web of Science ®Google Scholar
• Azar RR, Kassab R, Zoghbi A, Aboujaoude S, El-Osta H, Ghorra P, Germanos M, Salame E. Effects of clopidogrel on soluble cd40 ligand and on high-sensitivity c-reactive protein in patients with stable coronary artery disease. Am Heart J 2006;151:521.e521–521.e524
   Google Scholar
• Heitzer T, Rudolph V, Schwedhelm E, Karstens M, Sydow K, Ortak M, Tschentscher P, Meinertz T, Boger R, Baldus S. Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: Evidence for antioxidant and antiinflammatory effects. Arterioscler Thromb Vasc Biol 2006;26:1648–1652
   PubMed Web of Science ®Google Scholar
• Klinkhardt U, Bauersachs R, Adams J, Graff J, Lindhoff-Last E, Harder S. Clopidogrel but not aspirin reduces p-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther 2003;73:232–241
   PubMed Web of Science ®Google Scholar
• Quinn MJ, Bhatt DL, Zidar F, Vivekananthan D, Chew DP, Ellis SG, Plow E, Topol EJ. Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention. Am J Cardiol 2004;93:679–684
   PubMed Web of Science ®Google Scholar
• Vavuranakis M, Latsios G, Aggelis D, Bosinakou I, Karambelas I, Tousoulis D, Toutouzas K, Stefanadis C. Randomized comparison of the effects of asa plus clopidogrel versus asa alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity c-reactive protein and soluble CD40 ligand levels. Clin Ther 2006;28:860–871
   PubMed Web of Science ®Google Scholar
• Xiao Z, Theroux P. Clopidogrel inhibits platelet-leukocyte interactions and thrombin receptor agonist peptide-induced platelet activation in patients with an acute coronary syndrome. J Am Coll Cardiol 2004;43:1982–1988
   PubMed Web of Science ®Google Scholar
• Antonino MJ, Mahla E, Bliden KP, Tantry US, Gurbel PA. Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stenting. Am J Cardiol 2009;103:1546–1550
   PubMed Web of Science ®Google Scholar
• Braun OO, Johnell M, Varenhorst C, James S, Brandt JT, Jakubowski JA, Winters KJ, Wallentin L, Erlinge D, Siegbahn A. Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease. Thromb Haemost 2008;100:626–633
   PubMed Web of Science ®Google Scholar
• Frelinger AL III, Jakubowski JA, Li Y, Barnard MR, Fox ML, Linden MD, Sugidachi A, Winters KJ, Furman MI, Michelson AD. The active metabolite of prasugrel inhibits ADP-stimulated thrombo-inflammatory markers of platelet activation: Influence of other blood cells, calcium, and aspirin. Thromb Haemost 2007;98:192–200
   PubMed Web of Science ®Google Scholar
• Serebruany VL, Midei MG, Meilman H, Malinin AI, Lowry DR. Platelet inhibition with prasugrel (cs-747) compared with clopidogrel in patients undergoing coronary stenting: The subset from the jumbo study. Postgrad Med J 2006;82:404–410
   PubMed Web of Science ®Google Scholar
• Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009;361:1045–1057
   PubMed Web of Science ®Google Scholar
• Husted S, Storey RF, Harrington RA, Emanuelsson H, Cannon CP. Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrel. Clin Cardiol 2010;33:206–212
   PubMed Web of Science ®Google Scholar
• Gawaz M, Langer H, May AE. Platelets in inflammation and atherogenesis. J Clin Invest 2005;115:3378–3384
   PubMed Web of Science ®Google Scholar
• Blann AD, Nadar SK, Lip GY. The adhesion molecule p-selectin and cardiovascular disease. Eur Heart J 2003;24:2166–2179
   PubMed Web of Science ®Google Scholar
• Bienvenu JG, Tanguay JF, Theoret JF, Kumar A, Schaub RG, Merhi Y. Recombinant soluble p-selectin glycoprotein ligand-1-ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine. Circulation 2001;103:1128–1134
   PubMed Web of Science ®Google Scholar
• Hansen A, Kumar A, Wolf D, Frankenbergerova K, Filusch A, Gross ML, Mueller S, Katus H, Kuecherer H. Evaluation of cardioprotective effects of recombinant soluble p-selectin glycoprotein ligand-immunoglobulin in myocardial ischemia-reperfusion injury by real-time myocardial contrast echocardiography. J Am Coll Cardiol 2004;44:887–891
   PubMed Web of Science ®Google Scholar
• Hayward R, Campbell B, Shin YK, Scalia R, Lefer AM. Recombinant soluble p-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. Cardiovasc Res 1999;41:65–76
   PubMed Web of Science ®Google Scholar
• Kumar A, Villani MP, Patel UK, Keith JC Jr, Schaub RG. Recombinant soluble form of psgl-1 accelerates thrombolysis and prevents reocclusion in a porcine model. Circulation 1999;99:1363–1369
   PubMed Web of Science ®Google Scholar
• Wang K, Zhou X, Zhou Z, Tarakji K, Qin JX, Sitges M, Shiota T, Forudi F, Schaub RG, Kumar A, et al. Recombinant soluble p-selectin glycoprotein ligand-ig (rpsgl-ig) attenuates infarct size and myeloperoxidase activity in a canine model of ischemia-reperfusion. Thromb Haemost 2002;88:149–154
   PubMed Web of Science ®Google Scholar
• Mertens P, Maes A, Nuyts J, Belmans A, Desmet W, Esplugas E, Charlier F, Figueras J, Sambuceti G, Schwaiger M, et al. Recombinant p-selectin glycoprotein ligand-immunoglobulin, a p-selectin antagonist, as an adjunct to thrombolysis in acute myocardial infarction. The p-selectin antagonist limiting myonecrosis (psalm) trial. Am Heart J 2006;152:125.e121–125.e128
   Google Scholar
• Tanguay JF, Krucoff MW, Gibbons RJ, Chavez E, Liprandi AS, Molina-Viamonte V, Aylward PE, Lopez-Sendon JL, Holloway DS, Shields K, et al. Efficacy of a novel p-selectin antagonist, rpsgl-ig for reperfusion therapy in acute myocardial infarction: The rapsody trial. J Am Coll Cardiol 2003;41:404A–405A
   Web of Science ®Google Scholar
• Chelliah R, Lucking AJ, Tattersall L, Daga S, Beresford-Cleary NJ, Cortas K, Fox KA, Feuerstein GZ, Connolly TM, Newby DE. P-selectin antagonism reduces thrombus formation in humans. J Thromb Haemost 2009;7:1915–1919
   PubMed Web of Science ®Google Scholar
• Pamukcu B, Lip GY, Snezhitskiy V, Shantsila E. The CD40-CD40L system in cardiovascular disease. Ann Med 2011;43:331–340
   PubMed Web of Science ®Google Scholar
• Lutgens E, Cleutjens KB, Heeneman S, Koteliansky VE, Burkly LC, Daemen MJ. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc Natl Acad Sci USA 2000;97:7464–7469
   PubMed Web of Science ®Google Scholar
• Lutgens E, Gorelik L, Daemen MJ, de Muinck ED, Grewal IS, Koteliansky VE, Flavell RA. Requirement for cd154 in the progression of atherosclerosis. Nat Med 1999;5:1313–1316
   PubMed Web of Science ®Google Scholar
• Mach F, Schonbeck U, Sukhova GK, Atkinson E, Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998;394:200–203
   PubMed Web of Science ®Google Scholar
• Schonbeck U, Sukhova GK, Shimizu K, Mach F, Libby P. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc Natl Acad Sci USA 2000;97:7458–7463
   PubMed Web of Science ®Google Scholar
• Couzin J. Drug discovery. Magnificent obsession. Science 2005;307:1712–1715
   PubMed Web of Science ®Google Scholar
• Chauhan AK, Kisucka J, Brill A, Walsh MT, Scheiflinger F, Wagner DD. Adamts13: A new link between thrombosis and inflammation. J Exp Med 2008;205:2065–2074
   PubMed Web of Science ®Google Scholar
• Pendu R, Terraube V, Christophe OD, Gahmberg CG, de Groot PG, Lenting PJ, Denis CV. P-selectin glycoprotein ligand 1 and beta2-integrins cooperate in the adhesion of leukocytes to von willebrand factor. Blood 2006;108:3746–3752
   PubMed Web of Science ®Google Scholar
• Firbas C, Siller-Matula JM, Jilma B. Targeting von willebrand factor and platelet glycoprotein ib receptor. Expert Rev Cardiovasc Ther 2010;8:1689–1701
   PubMedGoogle Scholar
• Massberg S, Gawaz M, Gruner S, Schulte V, Konrad I, Zohlnhofer D, Heinzmann U, Nieswandt B. A crucial role of glycoprotein VI for platelet recruitment to the injured arterial wall in vivo. J Exp Med 2003;197:41–49
   PubMed Web of Science ®Google Scholar
• Bultmann A, Li Z, Wagner S, Peluso M, Schonberger T, Weis C, Konrad I, Stellos K, Massberg S, Nieswandt B, et al. Impact of glycoprotein vi and platelet adhesion on atherosclerosis – A possible role of fibronectin. J Mol Cell Cardiol 2010;49:532–542
   PubMed Web of Science ®Google Scholar
• Ungerer M, Li Z, Baumgartner C, Goebel S, Vogelmann J, Holthoff HP, Gawaz M, Munch G. The GPVI – FC fusion protein revacept reduces thrombus formation and improves vascular dysfunction in atherosclerosis without any impact on bleeding times. PLoS One 2013;8:e71193
   PubMed Web of Science ®Google Scholar
• Goebel S, Li Z, Vogelmann J, Holthoff HP, Degen H, Hermann DM, Gawaz M, Ungerer M, Munch G. The GPVI-FC fusion protein revacept improves cerebral infarct volume and functional outcome in stroke. PLoS One 2013;8:e66960
   PubMed Web of Science ®Google Scholar
• Ungerer M, Rosport K, Bultmann A, Piechatzek R, Uhland K, Schlieper P, Gawaz M, Munch G. Novel antiplatelet drug revacept (dimeric glycoprotein VI-FC) specifically and efficiently inhibited collagen-induced platelet aggregation without affecting general hemostasis in humans. Circulation 2011;123:1891–1899
   PubMed Web of Science ®Google Scholar
• Owens AP III, Mackman N. Microparticles in hemostasis and thrombosis. Circ Res 2011;108:1284–1297
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K, Fuller GL, Garcia A, Eble JA, Pohlmann S, Inoue O, Gartner TK, Hughan SC, Pearce AC, Laing GD, et al. A novel syk-dependent mechanism of platelet activation by the c-type lectin receptor CLEC-2. Blood 2006;107:542–549
   PubMed Web of Science ®Google Scholar
• Suzuki-Inoue K, Kato Y, Inoue O, Kaneko MK, Mishima K, Yatomi Y, Yamazaki Y, Narimatsu H, Ozaki Y. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells. J Biol Chem 2007;282:25993–26001
   PubMed Web of Science ®Google Scholar
• Herzog BH, Fu J, Wilson SJ, Hess PR, Sen A, McDaniel JM, Pan Y, Sheng M, Yago T, Silasi-Mansat R, et al. Podoplanin maintains high endothelial venule integrity by interacting with platelet CLEC-2. Nature 2013;502:105–109
   PubMed Web of Science ®Google Scholar